Andreas Maetzel, Ph.D.
Affiliations: | 2001 | University of Toronto, Toronto, ON, Canada |
Area:
Public Health, Health Care ManagementGoogle:
"Andreas Maetzel"Cross-listing: Epi Tree
Parents
Sign in to add mentor| Claire Bombardier | grad student | 2001 | University of Toronto (Epi Tree) | |
| (Economic evaluation of leflunomide in patients with rheumatoid arthritis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Benucci M, Stam WB, Gilloteau I, et al. (2013) Abatacept or infliximab for patients with rheumatoid arthritis and inadequate response to methotrexate: an Italian trial-based and real-life cost-consequence analysis. Clinical and Experimental Rheumatology. 31: 575-83 |
| Brosseau L, Wells GA, Kenny GP, et al. (2012) The implementation of a community-based aerobic walking program for mild to moderate knee osteoarthritis: a knowledge translation randomized controlled trial: part II: clinical outcomes. Bmc Public Health. 12: 1073 |
| Brosseau L, Wells GA, Kenny GP, et al. (2012) The implementation of a community-based aerobic walking program for mild to moderate knee osteoarthritis (OA): a knowledge translation (KT) randomized controlled trial (RCT): Part I: The Uptake of the Ottawa Panel clinical practice guidelines (CPGs). Bmc Public Health. 12: 871 |
| Boonen A, Maetzel A, Drummond M, et al. (2009) The OMERACT Initiative. Towards a reference approach to derive QALY for economic evaluations in rheumatology. The Journal of Rheumatology. 36: 2045-9 |
| Sander B, Elliot-Gibson V, Beaton DE, et al. (2008) A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. The Journal of Bone and Joint Surgery. American Volume. 90: 1197-205 |
| Clark P, Carlos F, Barrera C, et al. (2008) Direct costs of osteoporosis and hip fracture: An analysis for the Mexican healthcare system Osteoporosis International. 19: 269-276 |
| Osiri M, Kamolratanakul P, Maetzel A, et al. (2007) Cost effectiveness analysis of disease modifying antirheumatic drugs in rheumatoid arthritis. Rheumatology International. 27: 1063-9 |
| Osiri M, Maetzel A, Tugwell P. (2007) The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand. The Journal of Rheumatology. 34: 57-63 |
| Li LC, Maetzel A, Davis AM, et al. (2006) Primary therapist model for patients referred for rheumatoid arthritis rehabilitation: a cost-effectiveness analysis. Arthritis and Rheumatism. 55: 402-10 |
| Maetzel A. (2005) Cost-effectiveness analysis: out of touch with clinical reality? Arthritis and Rheumatism. 53: 3-4 |